Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lung Cancer-Derived Galectin-1 Mediates Dendritic Cell Anergy through Inhibitor of DNA Binding 3/IL-10 Signaling Pathway
Po-Lin Kuo, Jen‐Yu Hung, Shau-Ku Huang, et al.
The Journal of Immunology (2010) Vol. 186, Iss. 3, pp. 1521-1530
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Xiaoqi Mao, Jin Xu, Wei Wang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 1390
Altered Tumor-Cell Glycosylation Promotes Metastasis
Irina Häuselmann, Lubor Borsig
Frontiers in Oncology (2014) Vol. 4
Open Access | Times Cited: 336
Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer
Gabriel A. Rabinovich, Diego O. Croci
Immunity (2012) Vol. 36, Iss. 3, pp. 322-335
Open Access | Times Cited: 313
Galectin expression in cancer diagnosis and prognosis: A systematic review
Victor L. Thijssen, Roy Heusschen, Jo Caers, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2015) Vol. 1855, Iss. 2, pp. 235-247
Closed Access | Times Cited: 261
Glycobiology of immune responses
Gabriel A. Rabinovich, Yvette van Kooyk, Brian A. Cobb
Annals of the New York Academy of Sciences (2012) Vol. 1253, Iss. 1, pp. 1-15
Open Access | Times Cited: 248
Galectins and Immune Responses—Just How Do They Do Those Things They Do?
Sandra Thiemann, Linda G. Baum
Annual Review of Immunology (2016) Vol. 34, Iss. 1, pp. 243-264
Closed Access | Times Cited: 218
Biomarkers in Cancer Detection, Diagnosis, and Prognosis
Sreyashi Das, Mohan Kumar Dey, Ram V. Devireddy, et al.
Sensors (2023) Vol. 24, Iss. 1, pp. 37-37
Open Access | Times Cited: 93
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma
Diego O. Croci, Mariana Salatino, Natalia Rubinstein, et al.
The Journal of Experimental Medicine (2012) Vol. 209, Iss. 11, pp. 1985-2000
Open Access | Times Cited: 179
Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis
Ya-Ling Hsu, Jen‐Yu Hung, Shin-Yi Chiang, et al.
Oncotarget (2016) Vol. 7, Iss. 19, pp. 27584-27598
Open Access | Times Cited: 134
Tumor Microenvironment: A New Treatment Target for Cancer
Ming‐Ju Tsai, Wei‐An Chang, Ming‐Shyan Huang, et al.
ISRN Biochemistry (2014) Vol. 2014, pp. 1-8
Open Access | Times Cited: 130
The role of inflammation in the pathogenesis of lung cancer
William C. Cho, Chung Kong Kwan, Stephen Yau, et al.
Expert Opinion on Therapeutic Targets (2011) Vol. 15, Iss. 9, pp. 1127-1137
Closed Access | Times Cited: 129
Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell Apoptosis
Alice Banh, Jing Zhang, Hongbin Cao, et al.
Cancer Research (2011) Vol. 71, Iss. 13, pp. 4423-4431
Open Access | Times Cited: 125
Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/Snail signaling pathway
Y-L Hsu, Ming‐Feng Hou, P-L Kuo, et al.
Oncogene (2012) Vol. 32, Iss. 37, pp. 4436-4447
Open Access | Times Cited: 111
Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer
Alejandro J. Cagnoni, Juan M. Pérez Sáez, Gabriel A. Rabinovich, et al.
Frontiers in Oncology (2016) Vol. 6
Open Access | Times Cited: 110
CD5L Promotes M2 Macrophage Polarization through Autophagy-Mediated Upregulation of ID3
Lucía Sanjurjo, Gemma Aran, Érica Téllez, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 98
Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives
Kamil Wdowiak, Tomasz Francuz, Enrique Gallego-Colón, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 1, pp. 210-210
Open Access | Times Cited: 91
Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
Yifei Zhu, Xinyan Li, Lei Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 61
Galectin-1: A Traditionally Immunosuppressive Protein Displays Context-Dependent Capacities
Xizhi Yu, Junjie Qian, Limin Ding, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6501-6501
Open Access | Times Cited: 25
Identification of Lineage Relationships and Novel Markers of Blood and Skin Human Dendritic Cells
Andrew N. Harman, Christopher R. Bye, Najla Nasr, et al.
The Journal of Immunology (2012) Vol. 190, Iss. 1, pp. 66-79
Open Access | Times Cited: 90
Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway
Ya‐Ling Hsu, Cheng‐Ying Wu, Jen‐Yu Hung, et al.
Carcinogenesis (2013) Vol. 34, Iss. 6, pp. 1370-1381
Closed Access | Times Cited: 84
Wnt5a Skews Dendritic Cell Differentiation to an Unconventional Phenotype with Tolerogenic Features
Jaris Valencia, Carmen Hernández‐López, Víctor G. Martínez, et al.
The Journal of Immunology (2011) Vol. 187, Iss. 8, pp. 4129-4139
Open Access | Times Cited: 84
Galectin-1 inhibitors and their potential therapeutic applications: a patent review
Helen Blanchard, Khuchtumur Bum‐Erdene, M.H. Bohari, et al.
Expert Opinion on Therapeutic Patents (2016) Vol. 26, Iss. 5, pp. 537-554
Closed Access | Times Cited: 77
Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives
Jingbo Wang, Xue F. Huang, Furong Li
Cancer Communications (2019) Vol. 39, Iss. 1, pp. 1-11
Open Access | Times Cited: 75
Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment
María T. Elola, Fátima Ferragut, Santiago P. Méndez‐Huergo, et al.
Cellular Immunology (2018) Vol. 333, pp. 34-45
Open Access | Times Cited: 61
Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment
Yanyu Huang, Hsiao-Chi Wang, Junwei Zhao, et al.
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1398-1398
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top